ZLAB Zai Lab Limited - American Depositary Shares

NASDAQ · Biotechnology · View on SEC EDGAR ↗
$27.15
Price · Aug 19, 2026
Fundamentals as of Aug 6, 2026

About Zai Lab Limited - American Depositary Shares Company overview from Wikipedia

ZLAB Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$27.15
Market Cap
$30.38B
P/E (TTM)
-171.6
EPS (TTM)
$-0.16
Revenue (TTM)
$460M
Div Yield
ROE
-23.3%
Debt/Equity
0.3
52W Range
$16 – $36

ZLAB Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income $460M
8-point trend, +356610.1%
2018-12-31 2025-12-31
EPS $-0.16
6-point trend, +54.3%
2020-12-31 2025-12-31
Free Cash Flow $-159M
5-point trend, +29.8%
2020-12-31 2025-12-31
Margins -38.1%

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
ZLAB
Peer Median
P/E (TTM)
5-point trend, -33.3%
-171.6
21.9
P/S (TTM)
5-point trend, -82.5%
66.0
14.1
P/B
5-point trend, +168.4%
42.5
3.9
EV / EBITDA
2-point trend, +13.0%
-139.4
Price / FCF
5-point trend, -133.8%
-191.2

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
ZLAB
Peer Median
Operating Margin
5-point trend, +91.9%
-49.9%
Net Profit Margin
5-point trend, +93.1%
-38.1%
-36.0%
ROA
5-point trend, +54.2%
-14.9%
-20.8%
ROE
5-point trend, +0.0%
-23.3%
-29.7%
ROIC
3-point trend, +46.7%
-24.5%

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
ZLAB
Peer Median
Debt / Equity
2-point trend, +82.6%
0.3
3.9
Current Ratio
5-point trend, -80.3%
2.4
5.8
Quick Ratio
5-point trend, -84.3%
1.9

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
ZLAB
Peer Median
Revenue YoY
5-point trend, +218.9%
15.3%
Revenue CAGR 3Y
5-point trend, +218.9%
28.9%
Revenue CAGR 5Y
5-point trend, +218.9%
56.5%

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
ZLAB
Peer Median
EPS (Diluted)
5-point trend, +78.9%
$-0.16

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
ZLAB
Peer Median

ZLAB Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 14 analysts
  • Strong Buy 2 14.3%
  • Buy 9 64.3%
  • Hold 3 21.4%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

12 analysts · 2026-08-18
Median target $28.27 +4.1%
Mean target $32.18 +18.5%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
0.01%
Period EPS Actual EPS Est Surprise
June 30, 2026 $-0.05 $-0.07 0.02%
March 31, 2026 $-0.05 $-0.05 -0.00%
Dec. 31, 2025 $-0.05 $-0.07 0.02%
Sept. 30, 2025 $-0.03 $-0.04 0.01%
June 30, 2025 $-0.04 $-0.04 0.00%
March 31, 2025 $-0.05 $-0.07 0.02%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 16
Annual Income Statement data for ZLAB
Metric Trend 2025202420232022202120202019
Revenue 7-point trend, +3443.8% $460M $399M $267M $215M $144M $49M $13M
Cost of Revenue 7-point trend, +4981.9% $191M $147M $96M $74M $52M $17M $4M
R&D Expense 7-point trend, +55.3% $221M $235M $266M $286M $573M $223M $142M
SG&A Expense 7-point trend, +295.4% $278M $299M $282M $259M $219M $111M $70M
Operating Income 7-point trend, -12.9% $-229M $-282M $-367M $-404M $-700M $-302M $-203M
Interest Expense 6-point trend, +669.3% · $2M $0 $0 $0 $181.0K $293.0K
Interest Income 7-point trend, +301.5% $33M $37M $40M $15M $2M $5M $8M
Other Non-op 7-point trend, +277.4% $4M $5M $7M $3M $-10M $7M $938.0K
Pretax Income 7-point trend, +8.2% $-178M $-257M $-335M $-443M $-704M $-269M $-194M
Income Tax 6-point trend, -2927000.00 $-3M $0 $0 $0 $0 $0 ·
Net Income 7-point trend, +10.0% $-176M $-257M $-335M $-443M $-704M $-269M $-195M
EPS (Basic) 6-point trend, +54.3% $-0.16 $-0.26 $-0.35 $-0.46 $-0.76 $-0.35 ·
EPS (Diluted) 6-point trend, +54.3% $-0.16 $-0.26 $-0.35 $-0.46 $-0.76 $-0.35 ·
Shares (Basic) 6-point trend, +41.0% 1,095,311,090 989,477,730 966,394,130 958,067,140 929,921,120 776,677,430 ·
Shares (Diluted) 6-point trend, +41.0% 1,095,311,090 989,477,730 966,394,130 958,067,140 929,921,120 776,677,430 ·
EBITDA 5-point trend, +27.8% $-214M $-270M $-358M · $-694M $-297M ·
Balance Sheet 26
Annual Balance Sheet data for ZLAB
Metric Trend 2025202420232022202120202019
Cash & Equivalents 7-point trend, +795.0% $680M $450M $790M $1.01B $964M $442M $76M
Short-term Investments 7-point trend, -95.0% $10M $330M $16M $0 $445M $745M $200M
Receivables 7-point trend, +2699.2% $106M $85M $59M $40M $47M $5M $4M
Inventory 7-point trend, +1144.7% $75M $40M $45M $32M $19M $13M $6M
Prepaid Expense 7-point trend, +444.6% $37M $42M $23M $36M $18M $11M $7M
Current Assets 7-point trend, +248.5% $1.02B $1.05B $940M $1.12B $1.50B $1.22B $292M
PP&E (Net) 7-point trend, +121.9% $47M $48M $54M $58M $43M $29M $21M
PP&E (Gross) 7-point trend, +234.0% $90M $85M $84M $80M $60M $39M $27M
Accum. Depreciation 7-point trend, +672.1% $42M $37M $30M $22M $16M $10M $5M
Intangibles 7-point trend, +6532.8% $76M $56M $13M $2M $2M $2M $1M
Other Non-current Assets 2-point trend, -47.1% $3M $6M · · · · ·
Total Assets 7-point trend, +230.1% $1.17B $1.19B $1.04B $1.22B $1.61B $1.30B $355M
Accounts Payable 7-point trend, +524.9% $142M $101M $113M $66M $126M $63M $23M
Short-term Debt 4-point trend, +3071.0% $205M $132M $0 · · · $6M
Current Liabilities 7-point trend, +792.4% $416M $299M $203M $140M $193M $98M $47M
Capital Leases 7-point trend, +21.9% $13M $14M $8M $13M $10M $13M $11M
Other Non-current Liabilities 4-point trend, +0.00 $0 $325.0K $325.0K $0 · · ·
Total Liabilities 7-point trend, +655.3% $457M $345M $240M $175M $230M $128M $60M
Total Debt 2-point trend, +55.3% $205M $132M · · · · ·
Common Stock 7-point trend, +75.0% $7.0K $7.0K $6.0K $6.0K $6.0K $5.0K $4.0K
Retained Earnings 7-point trend, -491.1% $-2.63B $-2.45B $-2.20B $-1.86B $-1.42B $-714M $-445M
Treasury Stock 6-point trend, +29053000.00 $29M $21M $21M $12M $4M $0 ·
AOCI 7-point trend, +542.8% $30M $51M $38M $26M $-24M $-15M $5M
Stockholders' Equity 7-point trend, +142.8% $716M $841M $796M $1.05B $1.38B $1.17B $295M
Liabilities + Equity 7-point trend, +230.1% $1.17B $1.19B $1.04B $1.22B $1.61B $1.30B $355M
Shares Outstanding 7-point trend, +62.1% 1,106,389,340 1,082,614,740 977,151,270 962,455,850 955,363,980 878,110,260 682,372,470
Cash Flow 13
Annual Cash Flow data for ZLAB
Metric Trend 2025202420232022202120202019
D&A 7-point trend, +298.6% $15M $12M $9M $8M $6M $5M $4M
Stock-based Comp 7-point trend, +223.3% $66M $71M $80M $61M $41M $25M $20M
Amort. of Intangibles 7-point trend, +1834.4% $6M $3M $700.0K $500.0K $500.0K $300.0K $305.0K
Other Non-cash 5-point trend, -338.9% $-56M $-40M $48M · $108M $23M ·
Operating Cash Flow 7-point trend, +21.1% $-151M $-215M $-198M $-368M $-549M $-216M $-191M
CapEx 7-point trend, +34.2% $8M $6M $7M $25M $18M $10M $6M
Investing Cash Flow 7-point trend, +2167.3% $308M $-375M $-11M $420M $250M $-555M $-15M
Stock Issued 4-point trend, +0.00 $0 $217M $0 $0 · · ·
Net Stock Activity 2-point trend, -100.0% $0 $217M · · · · ·
Financing Cash Flow 7-point trend, -67.0% $72M $350M $-6M $-2M $820M $1.13B $219M
Net Change in Cash 7-point trend, +1604.3% $230M $-240M $-218M $44M $522M $366M $13M
Free Cash Flow 5-point trend, +29.8% $-159M $-221M $-205M · $-568M $-226M ·
Levered FCF · $-223M · · · · ·
Profitability 7
Annual Profitability data for ZLAB
Metric Trend 2025202420232022202120202019
Operating Margin 5-point trend, +91.9% -49.9% -70.7% -137.4% · -485.1% -616.5% ·
Net Margin 5-point trend, +93.1% -38.1% -64.4% -125.5% · -488.2% -549.3% ·
Pretax Margin 5-point trend, +92.9% -38.8% -64.4% -125.5% · -487.4% -549.3% ·
EBITDA Margin 5-point trend, +92.3% -46.6% -67.7% -134.1% · -480.6% -607.0% ·
ROA 5-point trend, +54.2% -14.9% -23.1% -29.7% · -48.5% -32.5% ·
ROE 5-point trend, +0.0% -23.3% -34.1% -39.9% · -47.5% -23.3% ·
ROIC 3-point trend, +46.7% -24.5% -29.0% -46.1% · · · ·
Liquidity & Solvency 4
Annual Liquidity & Solvency data for ZLAB
Metric Trend 2025202420232022202120202019
Current Ratio 5-point trend, -80.3% 2.4 3.5 4.6 · 7.8 12.4 ·
Quick Ratio 5-point trend, -84.3% 1.9 2.9 4.3 · 7.6 12.2 ·
Debt / Equity 2-point trend, +82.6% 0.3 0.2 · · · · ·
Interest Coverage 2-point trend, +92.5% · -125.2 · · · -1667.4 ·
Efficiency 3
Annual Efficiency data for ZLAB
Metric Trend 2025202420232022202120202019
Asset Turnover 5-point trend, +559.3% 0.4 0.4 0.2 · 0.1 0.1 ·
Inventory Turnover 5-point trend, +90.2% 3.3 3.5 2.5 · 3.3 1.7 ·
Receivables Turnover 5-point trend, -56.0% 4.8 5.5 5.4 · 5.5 10.9 ·
Per Share 5
Annual Per Share data for ZLAB
Metric Trend 2025202420232022202120202019
Book Value / Share 5-point trend, -95.1% $0.65 $0.78 $0.82 · $14.44 $13.32 ·
Revenue / Share 3-point trend, +52.2% $0.42 $0.40 $0.28 · · · ·
Cash Flow / Share 3-point trend, +32.9% $-0.14 $-0.22 $-0.21 · · · ·
Cash / Share 5-point trend, -87.8% $0.61 $0.42 $0.81 · $10.09 $5.03 ·
EPS (TTM) 6-point trend, +54.3% $-0.16 $-0.26 $-0.35 $-0.46 $-0.76 $-0.35 ·
Growth Rates 3
Annual Growth Rates data for ZLAB
Metric Trend 2025202420232022202120202019
Revenue YoY 5-point trend, -92.1% 15.3% 49.6% 24.0% 49.0% 194.8% · ·
Revenue CAGR 3Y 3-point trend, -62.0% 28.9% 40.4% 76.0% · · · ·
Revenue CAGR 5Y 56.5% · · · · · ·
Valuation (TTM) 14
Annual Valuation (TTM) data for ZLAB
Metric Trend 2025202420232022202120202019
Revenue TTM 6-point trend, +839.9% $460M $399M $267M $215M $144M $49M ·
Net Income TTM 6-point trend, +34.7% $-176M $-257M $-335M $-443M $-704M $-269M ·
Market Cap 5-point trend, +64.2% $19.52B $28.23B $26.57B · $6.00B $11.88B ·
Enterprise Value 2-point trend, -31.0% $19.03B $27.58B · · · · ·
P/E 6-point trend, +71.5% -110.2 -100.7 -78.1 -66.7 -82.7 -386.7 ·
P/S 5-point trend, -82.5% 42.4 70.7 99.6 · 41.6 242.7 ·
P/B 5-point trend, +168.4% 27.3 33.6 33.4 · 4.4 10.2 ·
P / Tangible Book 6-point trend, +200.0% 30.5 36.0 33.9 28.2 4.4 10.2 ·
P / Cash Flow 5-point trend, -135.3% -129.4 -131.4 -134.1 · -10.9 -55.0 ·
P / FCF 5-point trend, -133.8% -122.8 -128.0 -129.4 · -10.6 -52.5 ·
EV / EBITDA 2-point trend, +13.0% -88.8 -102.0 · · · · ·
EV / FCF 2-point trend, +4.2% -119.8 -125.1 · · · · ·
EV / Revenue 2-point trend, -40.2% 41.4 69.1 · · · · ·
Earnings Yield 6-point trend, -250.0% -0.91% -0.99% -1.3% -1.5% -1.2% -0.26% ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement
2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue $460M$399M$267M$215M$144M
Operating Margin % -49.9%-70.7%-137.4%-485.1%
Net Income $-176M$-257M$-335M$-443M$-704M
Diluted EPS $-0.16$-0.26$-0.35$-0.46$-0.76
Balance Sheet
2025-12-312024-12-312023-12-312022-12-312021-12-31
Debt / Equity 0.30.2
Current Ratio 2.43.54.67.8
Quick Ratio 1.92.94.37.6
Cash Flow
2025-12-312024-12-312023-12-312022-12-312021-12-31
Free Cash Flow $-159M$-221M$-205M$-568M

Latest News Recent headlines mentioning this company

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 99 filers · $767.0M total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
18 (-2 vs prior Q) 21 (-20 vs prior Q) 31 (+5 vs prior Q) 22 (-16 vs prior Q) +14.6M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
RTW INVESTMENTS, LP $124,906,608 6,574,032 16.29% Shares
TCG Crossover Management, LLC $116,614,913 6,137,627 15.20% Shares
RA CAPITAL MANAGEMENT, L.P. $109,127,127 5,743,533 14.23% Shares
ADAR1 Capital Management, LLC $64,011,646 3,369,034 8.35% Shares
GOLDMAN SACHS GROUP INC $43,994,120 2,315,480 5.74% Shares
Woodline Partners LP $41,938,567 2,207,293 5.47% Shares
Frazier Life Sciences Management, L.P. $36,144,080 1,902,320 4.71% Shares
BAMCO INC /NY/ $30,850,186 1,623,694 4.02% Shares
TWO SIGMA INVESTMENTS, LP $24,688,486 1,299,394 3.22% Shares
CITADEL ADVISORS LLC $24,409,414 1,284,706 3.18% Shares
FMR LLC $20,659,061 1,087,319 2.69% Shares
Rock Springs Capital Management LP $15,479,433 814,707 2.02% Shares
BlackRock, Inc. $12,163,002 640,158 1.59% Shares
B Group, Inc. $8,562,274 450,646 1.12% Shares
SCHRODER INVESTMENT MANAGEMENT GROUP $7,238,204 393,167 0.94% Shares
NAN FUNG TRINITY (HK) LTD $6,582,854 346,466 0.86% Shares
Aberdeen Group plc $5,914,586 311,294 0.77% Shares
CITIGROUP INC $5,714,706 300,774 0.75% Shares
Spruce Street Capital LP $5,303,090 279,110 0.69% Shares
AMERIPRISE FINANCIAL INC $4,808,539 253,081 0.63% Shares
BNP PARIBAS ASSET MANAGEMENT Holding S.A. $4,692,658 246,982 0.61% Shares
Hudson Bay Capital Management LP $4,085,000 215,000 0.53% Shares
JANE STREET GROUP, LLC $3,864,600 203,400 0.50% Put option
Nantahala Capital Management, LLC $3,800,000 200,000 0.50% Shares
NEXTBio Capital Management LP $3,483,878 183,362 0.45% Shares
SUPERSTRING CAPITAL MANAGEMENT LP $2,960,447 155,813 0.39% Shares
JANE STREET GROUP, LLC $2,934,702 154,458 0.38% Shares
Seven Fleet Capital Management LP $2,924,756 136,016 0.38% Shares
D. E. Shaw & Co., Inc. $2,682,002 141,158 0.35% Shares
Privium Fund Management B.V. $2,321,591 122,189 0.30% Shares
STATE STREET CORP $2,296,074 120,846 0.30% Shares
AXA Investment Managers S.A. $2,230,436 65,814 0.29% Shares
ALPS ADVISORS INC $2,098,189 110,431 0.27% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $2,086,200 109,800 0.27% Put option
DIMENSIONAL FUND ADVISORS LP $1,783,454 93,866 0.23% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $1,454,735 76,565 0.19% Shares
Orion Portfolio Solutions, LLC $1,310,400 36,259 0.17% Shares
Virtus Investment Advisers, LLC $1,294,356 68,124 0.17% Shares
Headlands Technologies LLC $1,292,190 68,010 0.17% Shares
DCF Advisers, LLC $1,206,500 63,500 0.16% Shares
CITADEL ADVISORS LLC $953,800 50,200 0.12% Put option
Quadrature Capital Ltd $741,532 39,028 0.10% Shares
WOLVERINE TRADING, LLC $714,581 21,700 0.09% Put option
WealthPlan Investment Management, LLC $698,459 36,761 0.09% Shares
GEODE CAPITAL MANAGEMENT, LLC $453,701 23,879 0.06% Shares
NJ State Employees Deferred Compensation Plan $382,957 11,300 0.05% Shares
XTX Topco Ltd $348,631 18,349 0.05% Shares
Schonfeld Strategic Advisors LLC $294,424 15,496 0.04% Shares
Squarepoint Ops LLC $291,004 15,316 0.04% Shares
Erste Asset Management GmbH $277,991 15,100 0.04% Shares
H D Vest Advisory Services $275,494 7,878 0.04% Shares
NORTHERN TRUST CORP $213,959 11,261 0.03% Shares
Vanguard Personalized Indexing Management, LLC $211,489 11,131 0.03% Shares
Persistent Asset Partners Ltd $209,760 11,040 0.03% Shares
TWO SIGMA SECURITIES, LLC $192,546 10,134 0.03% Shares
JPMORGAN CHASE & CO $122,592 6,659 0.02% Shares
China Universal Asset Management Co., Ltd. $99,560 5,240 0.01% Shares
GROUP ONE TRADING LLC $96,729 5,091 0.01% Shares
UBS Group AG $80,275 4,225 0.01% Shares
Mirae Asset Global Investments Co., Ltd. $74,594 3,926 0.01% Shares
SIMPLEX TRADING, LLC $50,483 2,657 0.01% Shares
Legal & General Group Plc $40,975 2,156 0.01% Shares
MARSHALL WACE, LLP $32,262 1,698 0.00% Shares
MORGAN STANLEY $27,645 1,455 0.00% Shares
Tower Research Capital LLC (TRC) $19,190 1,010 0.00% Shares
US BANCORP \DE\ $17,024 896 0.00% Shares
BNP PARIBAS FINANCIAL MARKETS $14,592 768 0.00% Shares
GF FUND MANAGEMENT CO. LTD. $13,851 729 0.00% Shares
Farther Finance Advisors, LLC $13,064 690 0.00% Shares
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC $11,813 628 0.00% Shares
C WorldWide Group Holding A/S $9,690 510,000 0.00% Shares
MERCER GLOBAL ADVISORS INC /ADV $8,949 471 0.00% Shares
Federation des caisses Desjardins du Quebec $5,700 300 0.00% Shares
BARCLAYS PLC $5,548 292 0.00% Shares
CWM, LLC $5,436 289 0.00% Shares
ROYAL BANK OF CANADA $4,000 222 0.00% Shares
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO $3,895 205 0.00% Shares
Arax Advisory Partners $3,819 201 0.00% Shares
ASSETMARK, INC $2,945 155 0.00% Shares
Quent Capital, LLC $2,850 150 0.00% Shares
DEUTSCHE BANK AG\ $2,793 147 0.00% Shares
Smartleaf Asset Management LLC $2,430 132 0.00% Shares
North Star Investment Management Corp. $1,843 97 0.00% Shares
Ameritas Advisory Services, LLC $1,444 76 0.00% Shares
EverSource Wealth Advisors, LLC $1,368 72 0.00% Shares
AMERIFLEX GROUP, INC. $1,178 62 0.00% Shares
WELLS FARGO & COMPANY/MN $1,140 60 0.00% Shares
Invesco Ltd. $779 41 0.00% Shares
OSAIC HOLDINGS, INC. $760 40 0.00% Shares
SBI Securities Co., Ltd. $760 40 0.00% Shares
Cornerstone Financial Management LLC $608 32 0.00% Shares
Caitong International Asset Management Co., Ltd $494 26 0.00% Shares
Bell Investment Advisors, Inc $494 26 0.00% Shares
PNC Financial Services Group, Inc. $494 26 0.00% Shares
Stone House Investment Management, LLC $418 22 0.00% Shares
Blue Trust, Inc. $95 5 0.00% Shares
Larson Financial Group LLC $76 4 0.00% Shares
Integrated Wealth Concepts LLC $57 3 0.00% Shares
BESSEMER GROUP INC $1 60 0.00% Shares

Company insiders 20 insiders · 11 officers · 10 directors

Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Ying Du Chairperson & CEO July 2, 2026 A 1,221,401 0 15 $-8,578,643
Yajing Chen Chief Financial Officer Aug. 14, 2026 M 35,895 0 7 $-232,240
William Ki Chul Cho Chief Financial Officer April 3, 2023 M 53,747 0 0 $0
Joshua L Smiley President and Chief Operating Officer April 6, 2026 S 117,602 1 4 $-245,924
Rafael Amado President, Head of Global Oncology Research and Development April 6, 2026 S 57,022 0 5 $-674,984
Harald Reinhart President and Head of Global Development for Neuroscience, Autoimmune and Infectious Diseases June 25, 2024 M 62,619 0 0 $0
Yi Liang CCO & President, Greater China June 25, 2022 A 104,847 0 0 $0
Tao Fu President & COO March 26, 2021 M 207,000 0 0 $0
Frazor Titus Edmondson III Chief Legal Officer June 25, 2026 M 30,346 0 9 $-1,073,729
Yizhe Wang Operating Partner May 11, 2026 A 0 0 $0
Alan B. Sandler Head of Global Dev., Oncology June 25, 2022 A 28,985 0 0 $0
Richard Gaynor Director July 1, 2026 P 80,737 2 0 $65,804
Nisa Leung Director June 17, 2026 A 96,297 0 0 $0
Michel Vounatsos Director June 17, 2026 A 72,787 0 0 $0
Scott W Morrison Director June 17, 2026 A 56,904 0 0 $0
John D. Diekman Director June 17, 2026 A 122,140 0 0 $0
MOULDER LEON O JR Director June 17, 2026 A 94,973 0 0 $0
WIRTH PETER Director June 17, 2026 A 416,121 0 0 $0
Kai-Xian Chen Director Dec. 31, 2024 D 39,525 0 0 $0
William Lis Aug. 12, 2026 S 41,931 0 2 $-340,004

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 13 ETFs

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
CANC · Tema ETF Trust 1.98% 196,972 NS May 31, 2026 N-PORT
BBP · ETFis Series Trust I 1.94% 53,256 NS April 30, 2026 N-PORT
SBIO · ALPS ETF Trust 1.26% 115,031 NS May 31, 2026 N-PORT
FMED · Fidelity Covington Trust 0.66% 15,273 NS May 31, 2026 N-PORT
PGJ · Invesco Exchange-Traded Fund Trust 0.48% 20,368 SH Aug. 8, 2026 Daily
IBB · iShares Trust 0.14% 659,407 SH Aug. 8, 2026 Daily
IBBQ · Invesco Exchange-Traded Fund Trust … 0.05% 1,795 SH Aug. 8, 2026 Daily
BIB · ProShares Trust 0.03% 1,269 NS May 31, 2026 N-PORT
DFEM · Dimensional ETF Trust 0.01% 28,261 NS April 30, 2026 N-PORT
DFSE · Dimensional ETF Trust 0.01% 1,660 NS April 30, 2026 N-PORT
EMCR · DBX ETF Trust 0.00% 147 NS May 29, 2026 N-PORT
DFAE · Dimensional ETF Trust 0.00% 17,797 NS April 30, 2026 N-PORT
DFAX · Dimensional ETF Trust 0.00% 2,911 NS April 30, 2026 N-PORT